Kyverna Moves Closer to First Autoimmune CAR-T Approval

Autolus Reports Encouraging CAR-T Data in Severe Lupus

FDA Signals Support for Autoimmune CAR-T Development

In Vivo CAR-T Shows Promise as Next-Generation Cell Therapy

CASTLE Trial Highlights Broad Potential Across Autoimmune Diseases

Novartis & Bristol Myers Squibb Pause Autoimmune CAR-T Trials Following Safety Reviews

The Jackson Laboratory

The Jackson Laboratory

The Jackson Laboratory